We did not observe an association between the use of statins or metformin and the stage of prostate cancer (Table 5) which suggests that men who use sta-tins and metformin have lower PSA levels but are not more likely to have a less (or more) advanced malignancy. This evidence concerns the gene KLK3 and prostate cancer.